Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Medical Bionic Implant Artificial Organs Companies

ID: MRFR/MED/4593-HCR
100 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Bionic Implant Artificial Organs Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.65%
2024 Market Size$ 24.5 Billion
2025 Market Size$ 26.17 Billion
2035 Market Size$ 45.05 Billion

Key Players

Medtronic
Abbott Laboratories
Boston Scientific
Cochlear Limited
Edwards Lifesciences
Stryker Corporation
Opportunities
  • Rising Investment in Research and Development
  • Increased Demand for Organ Replacement Solutions
  • Growing Awareness and Acceptance of Bionic Solutions

Top Industry Leaders in the Medical Bionic Implant Artificial Organs Market

Medical Bionic Implant/Artificial Organs Market
ย 

Latestย Medical Bionic Implant/Artificial Organsย Companiesย Updates:

Abbott Receives Breakthrough Designation for First Bionic Pancreas System:In October 2023, Abbott received a Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for its closed-loop bionic pancreas system. This system, currently under development, could revolutionize diabetes management by automatically adjusting insulin delivery based on real-time blood glucose levels.

SynCardia Announces Successful Implant of its Total Artificial Heart in Europe:In November 2023, SynCardia announced the successful implantation of its Freedom Destination total artificial heart in a patient in Europe. This marks a significant milestone for the company, as it brings its potentially life-saving technology closer to widespread use.

Second Sight Medical Products Secures โ‚ฌ74 Million Financing for its Artificial Retinal Prosthesis:In December 2023, Second Sight Medical Products secured โ‚ฌ74 million in financing to further develop and commercialize its Argus II retinal implant. This device helps restore some vision to patients with retinitis pigmentosa, a degenerative eye disease.

Ekso Bionics Partners with Ford to Develop Exoskeletons for Factory Workers:In January 2024, Ekso Bionics announced a partnership with Ford to develop and test exoskeletons that could reduce fatigue and prevent injuries for factory workers. This collaboration could pave the way for wider adoption of exoskeletons in the industrial sector.

Medtronic Launches AI-Powered Surgical Assistant for Joint Replacement Surgery:In January 2024, Medtronic launched its Mazor X Stealth Edition robotic surgical assistant for knee and hip replacement surgery. This system uses artificial intelligence to help surgeons plan and perform procedures with greater precision and accuracy.

List ofย Medical Bionic Implant/Artificial Organsย Key companies in the market:

  • Aleva Neurotherapeutics S.A. Switzerland
  • ย Biocontrol Medical Israel
  • ย Biomet, Inc. U.S.
  • Boston Scientific Corporation U.S.
  • ย Cochlear Ltd. (Australia), Cyberonics, Inc. U.S.
  • ย Ekso Bionics U.S.
  • ย LivaNova PLC U.K.
  • ย Medtronic, Inc. U.S.
  • ย NeuroPace, Inc. U.S.
  • Orthofix International N.V. The Netherlands
  • ย Ossur Iceland